BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16021176)

  • 1. Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment.
    Stiehm ER; Roberts RL; Kaplan MS; Corren J; Jaracz E; Rico MJ
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S206-13. PubMed ID: 16021176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
    Hidalgo H; Moore C; Leiva LE; Sorensen RU
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination.
    Papp KA; Breuer K; Meurer M; Ortonne JP; Potter PC; de Prost Y; Davidson MJ; Barbier N; Goertz HP; Paul C
    J Am Acad Dermatol; 2005 Feb; 52(2):247-53. PubMed ID: 15692469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
    Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
    Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-immunization pneumococcal antibody titers and IgG subclasses.
    Sorensen RU; Hidalgo H; Moore C; Leiva LE
    Pediatr Pulmonol; 1996 Sep; 22(3):167-73. PubMed ID: 8893255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.
    Bogaert D; Veenhoven RH; Ramdin R; Luijendijk IH; Rijkers GT; Sanders EA; de Groot R; Hermans PW
    Vaccine; 2005 Apr; 23(20):2607-13. PubMed ID: 15780443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective deficiency in pneumococcal antibody response in children with recurrent infections.
    Epstein MM; Gruskay F
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):125-31. PubMed ID: 7648376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants.
    Spoulou V; Victoratos P; Ioannidis JP; Grafakos S
    J Infect Dis; 2000 Sep; 182(3):965-9. PubMed ID: 10950799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
    J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion.
    van Heerbeek N; Straetemans M; Wiertsema SP; Ingels KJ; Rijkers GT; Schilder AG; Sanders EA; Zielhuis GA
    Pediatrics; 2006 Mar; 117(3):603-8. PubMed ID: 16510637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia.
    Hedlund JU; Kalin ME; Ortqvist AB; Henrichsen J
    Arch Intern Med; 1994 Sep; 154(17):1961-5. PubMed ID: 8074600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma.
    Lahood N; Emerson SS; Kumar P; Sorensen RU
    Ann Allergy; 1993 Apr; 70(4):289-94. PubMed ID: 8466093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
    Patel RR; Vander Straten MR; Korman NJ
    Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune response in splenectomized children to anti-pneumococcal vaccination].
    Hartmann JF; Buriot D; Griscelli C
    Arch Fr Pediatr; 1985 May; 42(5):345-51. PubMed ID: 4074086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.
    Hanifin JM; Paller AS; Eichenfield L; Clark RA; Korman N; Weinstein G; Caro I; Jaracz E; Rico MJ;
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S186-94. PubMed ID: 16021174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients.
    Koo JY; Fleischer AB; Abramovits W; Pariser DM; McCall CO; Horn TD; Gottlieb AB; Jaracz E; Rico MJ
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S195-205. PubMed ID: 16021175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to a 14-valent pneumococcal polysaccharide vaccine in the elderly.
    Schouten J
    Pharmatherapeutica; 1981; 3(1):1-5. PubMed ID: 7323105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis.
    Chapman MS; Schachner LA; Breneman D; Boguniewicz M; Gold MH; Shull T; Linowski GJ; Jaracz E;
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S177-85. PubMed ID: 16021173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.